相似文献
1
Effectiveness of biologics in rheumatology: improving the evidence base.
Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv1-2. doi: 10.1093/rheumatology/ker238.
2
[Evidence based medicine in rheumatology].
Z Rheumatol. 2002 Oct;61(5):516-8. doi: 10.1007/s00393-002-0442-2.
3
[National registry for a new and costly treatment].
Tidsskr Nor Laegeforen. 2008 Aug 14;128(15):1654.
4
[Salvage therapy and difficult treatment situations].
Z Rheumatol. 2016 Dec;75(10):954-955. doi: 10.1007/s00393-016-0226-8.
5
Use of biologic agents in rheumatoid arthritis: introduction.
Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv3-4. doi: 10.1093/rheumatology/ker239.
6
Clinical trials in rheumatology. Does one size fit all?
Rheumatology (Oxford). 2017 May 1;56(5):675-676. doi: 10.1093/rheumatology/kew253.
7
8
[Non-TNF biologicals in therapy].
Z Rheumatol. 2010 Sep;69(7):579-80. doi: 10.1007/s00393-009-0527-2.
9
The Corrona US registry of rheumatic and autoimmune diseases.
Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S96-S99. Epub 2016 Oct 19.
10
BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.
Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.
Zotero 插件